PI Vs. NNRTI Based Therapy for HIV Advanced Disease
Status:
Unknown status
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
Ritonavir boosted protease inhibitor based therapy will have equivalent antiviral efficacy
over 48 weeks compared to NNRTI based therapy in patients who are antiretroviral therapy
naïve and initiate therapy with CD4 counts ≤ 200/mm3.
Phase:
Phase 4
Details
Lead Sponsor:
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Collaborators:
Instituto Mexicano del Seguro Social National Council of Science and Technology, Mexico